Drug combinations in diabetic neuropathic pain: an experimental validation
- 22 June 2016
- journal article
- research article
- Published by Walter de Gruyter GmbH in Journal of Basic and Clinical Physiology and Pharmacology
- Vol. 27 (6) , 617-624
Abstract
Background: Diabetic neuropathy is the most common complication of diabetes mellitus, and the different drug combinations available do not provide effective pain relief. The present study was performed to observe the effect of amitripyline, duloxetine, sitagliptin, and pregabalin, and their combinations on streptozotocin (STZ)-induced diabetic neuropathy. Methods: Diabetic neuropathy was induced by STZ, and the tail-flick test was used to assess thermal hyperalgesia before and after (at 30, 60, and 120 min) drug administration. One week after STZ administration, the blood glucose level was observed to be in the diabetic range. Results: Administration of all the drugs except sitagliptin increased the tail-flick latency significantly as compared to control. Further, the drugs amitriptyline, duloxetine, and pregabalin showed significant pain-relieving effect, when either two of them were administered in combination, although the different combinations had varied degree of pain relief. However, sitagliptin was observed to have no effect when administered alone or in combination with the other three drugs. Conclusions: Therefore, the study provides new insights concerning combined therapy of pain, which further needs clinical exploration.Keywords
This publication has 41 references indexed in Scilit:
- Protection of Trigonelline on Experimental Diabetic Peripheral NeuropathyEvidence-Based Complementary and Alternative Medicine, 2012
- Sitagliptin, sitagliptin and metformin, or sitagliptin and amitriptyline attenuate streptozotocin-nicotinamide induced diabetic neuropathy in ratsJournal of Biomedical Research, 2012
- Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature UpdateMayo Clinic Proceedings, 2010
- Animal models and biomarkers of neuropathy in diabetic rodentsIndian Journal of Pharmacology, 2010
- Controlled-Release Oxycodone and Pregabalin in the Treatment of Neuropathic Pain: Results of a Multicenter Italian StudyEuropean Neurology, 2008
- Diabetic Painful NeuropathyDrugs, 2007
- Efficacy of Duloxetine, a Potent and Balanced Serotonergic and Noradrenergic Reuptake Inhibitor, in Inflammatory and Acute Pain Models in RodentsThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Effects of the suppression of acute herpetic pain by gabapentin and amitriptyline on the incidence of delayed postherpetic pain in miceLife Sciences, 2004
- Streptozocin-Induced Neuropathy Is Associated with Altered Expression of Voltage-Gated Calcium Channel Subunit mRNAs in Rat Dorsal Root Ganglion NeuronesBiochemical and Biophysical Research Communications, 2001
- Inhibition of uptake, steady‐state currents, and transient charge movements generated by the neuronal GABA transporter by various anticonvulsant drugsBritish Journal of Pharmacology, 1999